These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 38247856
1. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E. Cells; 2024 Jan 16; 13(2):. PubMed ID: 38247856 [Abstract] [Full Text] [Related]
2. Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis. Tarique AA, Evron T, Zhang G, Tepper MA, Morshed MM, Andersen ISG, Begum N, Sly PD, Fantino E. J Cyst Fibros; 2020 Sep 16; 19(5):823-829. PubMed ID: 32387042 [Abstract] [Full Text] [Related]
3. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Am J Respir Cell Mol Biol; 2009 Nov 16; 41(5):590-602. PubMed ID: 19244203 [Abstract] [Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function. Zhang S, Shrestha CL, Kopp BT. Sci Rep; 2018 Nov 20; 8(1):17066. PubMed ID: 30459435 [Abstract] [Full Text] [Related]
5. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. Zhang B, Bailey WM, Kopper TJ, Orr MB, Feola DJ, Gensel JC. J Neuroinflammation; 2015 Nov 24; 12():218. PubMed ID: 26597676 [Abstract] [Full Text] [Related]
6. Long term azithromycin therapy in patients with cystic fibrosis. Emiralioğlu N, Öztürk Z, Yalçın E, Doğru D, Özçelik U, Kiper N. Turk J Pediatr; 2016 Nov 24; 58(1):34-40. PubMed ID: 27922234 [Abstract] [Full Text] [Related]
7. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. Bergamini G, Cigana C, Sorio C, Della Peruta M, Pompella A, Corti A, Huaux FA, Leal T, Assael BM, Melotti P. Am J Respir Cell Mol Biol; 2009 Aug 24; 41(2):199-206. PubMed ID: 19097986 [Abstract] [Full Text] [Related]
8. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Høiby N. Antimicrob Agents Chemother; 2007 Oct 24; 51(10):3677-87. PubMed ID: 17620382 [Abstract] [Full Text] [Related]
9. Azithromycin alters Colony Stimulating Factor-1R (CSF-1R) expression and functional output of murine bone marrow-derived macrophages: A novel report. Yadav S, Dalai P, Gowda S, Nivsarkar M, Agrawal-Rajput R. Int Immunopharmacol; 2023 Oct 24; 123():110688. PubMed ID: 37499396 [Abstract] [Full Text] [Related]
10. Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. Cory TJ, Birket SE, Murphy BS, Hayes D, Anstead MI, Kanga JF, Kuhn RJ, Bush HM, Feola DJ. J Cyst Fibros; 2014 Mar 24; 13(2):164-71. PubMed ID: 24018177 [Abstract] [Full Text] [Related]
11. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo. Li Y, Huang J, Li L, Liu L. Cell Physiol Biochem; 2017 Mar 24; 42(4):1657-1669. PubMed ID: 28738346 [Abstract] [Full Text] [Related]
12. (R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages. Shrestha CL, Zhang S, Wisniewski B, Häfner S, Elie J, Meijer L, Kopp BT. Sci Rep; 2020 Dec 10; 10(1):21700. PubMed ID: 33303916 [Abstract] [Full Text] [Related]
13. Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice. Tsai WC, Hershenson MB, Zhou Y, Sajjan U. Inflamm Res; 2009 Aug 10; 58(8):491-501. PubMed ID: 19271151 [Abstract] [Full Text] [Related]
14. Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa. Barnaby R, Koeppen K, Nymon A, Hampton TH, Berwin B, Ashare A, Stanton BA. Am J Physiol Lung Cell Mol Physiol; 2018 Mar 01; 314(3):L432-L438. PubMed ID: 29146575 [Abstract] [Full Text] [Related]
15. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes. Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL. Pediatr Pulmonol; 2007 Jun 01; 42(6):533-41. PubMed ID: 17469154 [Abstract] [Full Text] [Related]
16. Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity. Zhang B, Kopper TJ, Liu X, Cui Z, Van Lanen SG, Gensel JC. CNS Neurosci Ther; 2019 May 01; 25(5):591-600. PubMed ID: 30677254 [Abstract] [Full Text] [Related]
17. MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection. De M, Serpa G, Zuiker E, Hisert KB, Liles WC, Manicone AM, Hemann EA, Long ME. Front Cell Infect Microbiol; 2024 May 01; 14():1275940. PubMed ID: 38352056 [Abstract] [Full Text] [Related]
18. [Azithromycin therapy in cystic fibrosis]. Máiz Carro L, Cantón Moreno R. Med Clin (Barc); 2004 Mar 06; 122(8):311-6. PubMed ID: 15030744 [Abstract] [Full Text] [Related]
19. Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response. Poerio N, De Santis F, Rossi A, Ranucci S, De Fino I, Henriquez A, D'Andrea MM, Ciciriello F, Lucidi V, Nisini R, Bragonzi A, Fraziano M. Front Immunol; 2020 Mar 06; 11():532225. PubMed ID: 33117337 [Abstract] [Full Text] [Related]
20. Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. Tarique AA, Sly PD, Cardenas DG, Luo L, Stow JL, Bell SC, Wainwright CE, Fantino E. J Cyst Fibros; 2019 May 06; 18(3):342-348. PubMed ID: 30177416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]